Apellis Pharmaceuticals, Inc.
1 appearance
Latest appearance 2026-01-12
Caroline Baumal
Apellis Pharmaceuticals, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Caroline Baumal
The proxy statement of Apellis Pharmaceuticals, Inc. reports total compensation of $4,407,128 for Caroline Baumal in fiscal 2024, including a base salary of $610,386. Disclosed compensation is on record for 2 fiscal years. Caroline Baumal has spoken on 1 earnings call across 1 company, most recently for Apellis Pharmaceuticals, Inc. on January 12, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Apellis Pharmaceuticals, Inc.
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Apellis Pharmaceuticals, Inc. | Chief Medical Officer | $610,386 | $4,407,128 |
| 2023 | Apellis Pharmaceuticals, Inc. | Chief Medical Officer | $550,673 | $4,430,459 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
Earnings call
Apellis Pharmaceuticals, Inc. Q4 FY2025 Earnings Call
Apellis Pharmaceuticals, Inc.